Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2014
08/07/2014US20140221457 Ameliorating oxidative stress in neurodegenerative disease via nox1 targeting
08/07/2014US20140221442 Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
08/07/2014US20140221439 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
08/07/2014US20140221421 Therapeutic compounds
08/07/2014US20140221415 Method of Treating Dyskinesia
08/07/2014US20140221395 Deuterium-Enriched Alkyl Sulfonamides and Uses Thereof
08/07/2014US20140221388 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
08/07/2014US20140221383 Cetp inhibitors
08/07/2014US20140221380 SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
08/07/2014US20140221370 Pyrrolopyridines as kinase inhibitors
08/07/2014US20140221365 Alkylated piperazine compounds
08/07/2014US20140221361 C-19 modified triterpenoids with hiv maturation inhibitory activity
08/07/2014US20140221356 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
08/07/2014US20140221354 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY
08/07/2014US20140221349 Indanyloxydihydrobenzofuranylacetic acids
08/07/2014US20140221347 Therapeutic compounds
08/07/2014US20140221346 Therapeutic compounds
08/07/2014US20140221330 Ndm inhibitor
08/07/2014US20140221326 Ophthalmologic irrigation solutions and method
08/07/2014US20140221322 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
08/07/2014US20140221307 In-situ gel forming compositions
08/07/2014US20140221304 5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
08/07/2014US20140221294 Sulphated hyaluronic acid for treating degenerative osteoarthritis
08/07/2014US20140221291 Compositions and Methods for Modulating Thrombin Generation
08/07/2014US20140221286 Sodium channel blockers reduce glucagon secretion
08/07/2014US20140221281 Dual glp1/gip or trigonal glp1/gip/glucagon agonists
08/07/2014US20140221277 Method For Elevating Prolactin In Mammals
08/07/2014US20140220181 Method of Hydration; Infusion Packet System(s), Support Member(s), Delivery System(s), and Method(s); with Business Model(s) and Method(s)
08/07/2014US20140220165 Compositions for the treatment of peripheral ulcers of various origins
08/07/2014US20140220150 Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD): methods and compositions
08/07/2014US20140220132 Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family
08/07/2014US20140220109 Novel cochleate formulations
08/07/2014US20140220074 Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
08/07/2014US20140220050 Novel immunomodulator and anti-inflammatory compounds
08/07/2014US20140220049 Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
08/07/2014US20140220044 Method for the production of hydrolyzed allergens
08/07/2014US20140220033 Administration of an Anti-Activin-A Compound to a Subject
08/07/2014US20140220032 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
08/07/2014US20140220029 Combined use of a modulator of cd3 and a glp-1 compound
08/07/2014US20140220024 Chymase compositions, antibodies, diagnostics, and therapeutic methods related thereto
08/07/2014US20140220023 Method of treating osteoarthritis with an antibody to ngf
08/07/2014US20140220020 Il-1 binding proteins
08/07/2014US20140220016 Antibody- endostatin fusion protein and its variants
08/07/2014US20140220013 Method for the diagnosis and prognosis of malignant diseases
08/07/2014US20140220012 Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders
08/07/2014US20140220011 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
08/07/2014US20140220004 Compositions and methods for treating pain
08/07/2014US20140220003 Therapeutic method for mesothelioma
08/07/2014US20140219997 Templated Islet Cells and Small Islet Cell Clusters for Diabetes Treatment
08/07/2014US20140219996 Ruthenium carbon monoxide releasing molecules and uses thereof
08/07/2014US20140219995 Inhibitors of bacterial type iii secretion system
08/07/2014US20140219989 Factor ixa inhibitors
08/07/2014US20140219981 Amphiphilic peptides and hydrogel matrices thereof for bone repair
08/07/2014US20140219970 Treatment of sarcoidosis using placental stem cells
08/07/2014US20140219965 Controlling appetite, promoting weight loss, reducing body fat, and/or improving glucose tolerance
08/07/2014US20140219959 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins
08/07/2014US20140219958 5, 6-d2 uridine nucleoside/tide derivatives
08/07/2014US20140219957 Methods and compositions for the treatment of immune disorders
08/07/2014US20140219914 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
08/07/2014US20140219913 Dual Specific Binding Proteins Having a Receptor Sequence
08/07/2014US20140219912 Dual variable domain immunoglobulins and uses thereof
08/06/2014EP2762140A1 Treatment of solid brain tumours with a rapamycin derivative
08/06/2014EP2762125A1 Improved dermatological composition
08/06/2014EP2760473A1 Compositions and methods of treating gliomas
08/06/2014EP2760456A1 Combination therapy for chemoresistant cancers
08/06/2014EP2760449A1 A pharmaceutical composition for the treatment of stem cells
08/06/2014EP2760445A1 Method of treating mucoepidermoid carcinoma
08/06/2014EP2760440A1 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
08/06/2014CN103974694A 用于治疗干眼病的组合物 For the treatment of dry eye compositions
08/06/2014CN103961711A Nampt抑制剂协同nqo1底物在治疗人非小细胞肺癌中的应用 Nampt inhibitor collaborative nqo1 substrates used in the treatment of non-small cell lung cancer
08/06/2014CN103961710A 骨科术后关节组织用防粘连粉雾剂及其制备方法 Postoperative orthopedic joint tissue with anti-adhesion and preparation method of inhalation
08/06/2014CN103961709A 组蛋白甲基转移酶抑制剂与化疗剂组合在治疗肿瘤中的用途 In combination with chemotherapeutic agents histone methyltransferase inhibitor use in the treatment of tumors
08/06/2014CN103961708A 一种骨科术后用防粘连粉雾剂及其制备方法 An anti-adhesion postoperative orthopedic and preparation method of inhalation
08/06/2014CN103961707A 抗病毒药在制备治疗末稍神经病变疾病药物中的应用 In the preparation of antiviral treatment of peripheral neuropathy diseases medicament
08/06/2014CN103961706A 微小rna或其抑制剂在脂代谢调控中的应用 Small rna or inhibitors in the regulation of lipid metabolism
08/06/2014CN103961693A 一种恶性肿瘤治疗性疫苗及其组合物 A malignant tumor therapeutic vaccine and composition
08/06/2014CN103223173B 具有温控开关的囊状聚氨酯药物控释体及其制备方法 Cystic polyurethane drug delivery and preparation method of temperature control switch
08/06/2014CN103083284B 膜状制剂及其制备方法 Membranous and its preparation method
08/06/2014CN102813840B 一种药物组合物在制备预防和治疗糖尿病心肌病的药物中的应用 A pharmaceutical composition in the manufacture of drug prevention and treatment of diabetic cardiomyopathy in
08/06/2014CN102573911B 一种内含用以治疗神经退化性疾病的立即释出与长效释出药物的口服剂量配方 For the treatment of one kind of containing neurodegenerative diseases immediate release and long-acting drug release oral dosage formulations
08/06/2014CN102238964B NSAIDs诱因消化道粘膜损伤抑制剂及其制造方法 NSAIDs cause of gastrointestinal mucosal injury inhibitor and its manufacturing method
08/06/2014CN101948541B 用于肿瘤诊断和治疗的组合物和方法 Compositions and methods for tumor diagnosis and treatment
08/05/2014US8798933 Frozen compositions and methods for piercing a substrate
08/05/2014US8798932 Frozen compositions and methods for piercing a substrate
08/05/2014US8796337 Composition and method for treating neurological disease
08/05/2014US8796331 Methods of treatment and pharmaceutical composition
08/05/2014US8796317 Use of 7-nitro-2,1,3-benzoxadiazole derivatives for anticancer therapy
08/05/2014US8796300 Therapeutic compounds
08/05/2014US8796299 NK1 antagonists
08/05/2014US8796257 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
08/05/2014US8796250 Diaryl ureas for diseases mediated by PDGFR
08/05/2014US8796247 Indole derivative, and pharmacologically acceptable salt thereof
08/05/2014US8796245 C7-fluoro substituted tetracycline compounds
08/05/2014US8796241 Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase
08/05/2014US8796208 Methods and compositions for regenerating articular cartilage
08/05/2014US8796016 RNA interference mediating small RNA molecules
08/05/2014US8795741 Methods for treating patients who are candidates for inhaled nitric oxide treatment
08/05/2014US8795684 Agent for use in the topical or local treatment of cervical dysplasias
08/05/2014US8795653 Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
08/05/2014US8795652 Methods and compositions to treat myocardial conditions
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 1151